Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-060395

SVP and General Counsel sold 2,880 shares at an average $46.31 ($133,359)

  • SVP and General Counsel acquired 2,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-23 Exercise or conversion : show line 1 in the form +1,109 $7.80 $8,650 2,409 D
2020-11-23 Exercise or conversion : show line 2 in the form +1,771 $6.55 $11,600 4,180 D
2020-11-23 Sale : show line 3 in the form −23 $45.69 $1,051 4,157 D
2020-11-23 Sale : show line 4 in the form −2,857 $46.31 $132,308 1,300 D
Open-market sales · 2,880 sh · avg $46.31 · $133,359

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-11-23 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,109 33,926 D
2020-11-23 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −1,771 28,334 D
Loading xslF345X03/doc4.xml…